|
MRPS31 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.46900000444583E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.16250000018015E-07 |
| Normal-vs-Stage2 |
5.703400E-03 |
| Normal-vs-Stage3 |
1.037770E-04 |
| Normal-vs-Stage4 |
1.761710E-02 |
| Stage1-vs-Stage2 |
8.645800E-01 |
| Stage1-vs-Stage3 |
1.248190E-01 |
| Stage1-vs-Stage4 |
4.429000E-01 |
| Stage2-vs-Stage3 |
3.042400E-01 |
| Stage2-vs-Stage4 |
6.257000E-01 |
| Stage3-vs-Stage4 |
7.188000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.46739994891732E-09 |
| Normal-vs-AfricanAmerican |
2.647600E-04 |
| Normal-vs-Asian |
1.73560000005235E-06 |
| Caucasian-vs-AfricanAmerican |
3.562200E-01 |
| Caucasian-vs-Asian |
2.062600E-03 |
| AfricanAmerican-vs-Asian |
9.381200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18270004900722E-09 |
| Normal-vs-Female |
1.78603999999583E-05 |
| Male-vs-Female |
3.334800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.216800E-04 |
| Normal-vs-Extreme_Weight |
9.14620001957189E-09 |
| Normal-vs-Obese |
4.37379999995713E-06 |
| Normal-vs-Extreme_Obese |
2.868600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.210200E-01 |
| Normal_Weight-vs-Obese |
8.947000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.623000E-01 |
| Extreme_Weight-vs-Obese |
5.843400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.932200E-01 |
| Obese-vs-Extreme_Obese |
3.830800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.974030E-04 |
| Normal-vs-Age(41-60Yrs) |
2.0404999999668E-06 |
| Normal-vs-Age(61-80Yrs) |
4.59229998472921E-09 |
| Normal-vs-Age(81-100Yrs) |
4.341000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.279800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.338800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.512600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.417020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.940100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.246800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.54499999857916E-08 |
| Normal-VS-Type2 PRCC |
4.46000000042801E-07 |
| Normal-VS-KIRP CIMP |
1.0664025218432E-11 |
| Normal-VS-Unclassified PRCC |
9.372000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.329000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.470399999981E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.948400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.419600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.343200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.248200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.3264999994892E-07 |
| Normal-vs-N1 |
1.775600E-02 |
| Normal-vs-N2 |
1.76969999765575E-08 |
| N0-vs-N1 |
7.505200E-01 |
| N0-vs-N2 |
4.718300E-03 |
| N1-vs-N2 |
4.535600E-02 |
|
|
